Literature DB >> 3347207

Aberrant DNA repair and enhanced mutagenesis following mutagen treatment of Chinese hamster Ade-C cells in a state of purine deprivation.

A R Collins1, D T Black, C A Waldren.   

Abstract

Ade-C is a Chinese hamster ovary cell line auxotrophic for purines because of a mutation in the de novo synthetic pathway. We now show that, in the absence of exogenous hypoxanthine, replicative DNA synthesis is rapidly shut down. Various aspects of DNA repair have been studied in purine-starved cells. Incision, the first step of excision repair of UV damage, appears normal, as do the later steps, repair synthesis (demonstrated following chemical damage as well as UV-irradiation) and ligation. However, removal of UV-induced pyrimidine dimers is not detected, and it seems that the repair that occurs is aberrant. This behaviour is associated with an increase in cell killing by UV light, and a several-fold increase in the frequency of mutations induced by UV.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3347207     DOI: 10.1016/0167-8817(88)90045-4

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Dietary folic acid protects against genotoxicity in the red blood cells of mice.

Authors:  Amanda J MacFarlane; Nathalie A Behan; Martha S Field; Andrew Williams; Patrick J Stover; Carole L Yauk
Journal:  Mutat Res       Date:  2015-06-29       Impact factor: 2.433

2.  Azoxymethane-induced colon carcinogenesis in mice occurs independently of de novo thymidylate synthesis capacity.

Authors:  Amanda J MacFarlane; Michael F McEntee; Patrick J Stover
Journal:  J Nutr       Date:  2014-02-05       Impact factor: 4.798

3.  Mthfd1 is a modifier of chemically induced intestinal carcinogenesis.

Authors:  Amanda J MacFarlane; Cheryll A Perry; Michael F McEntee; David M Lin; Patrick J Stover
Journal:  Carcinogenesis       Date:  2010-12-14       Impact factor: 4.944

4.  Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk.

Authors:  Amanda J Macfarlane; Cheryll A Perry; Michael F McEntee; David M Lin; Patrick J Stover
Journal:  Cancer Res       Date:  2011-03-15       Impact factor: 12.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.